Abbott will pay $1.6 billion in a settlement with U.S. federal and 49 state authorities, plus the District of Columbia, to resolve all outstanding allegations regarding past sales and marketing practices for its neurologic drug Depakote. The settlement follows a four-year investigation into past Depakote sales activities that began in 1998. Abbott will pay $800 million to resolve civil allegations, federal and state governments, $700 million for a criminal penalty, and $100 million to states to...